vimarsana.com
Home
Live Updates
Clinical research dalarna
Live Breaking News & Updates on Clinical research dalarna
Time to Add aHSCT to Standard Care in RRMS?
73% of patients with relapsing remitting multiple sclerosis were disease free 5 years after aHSCT treatment, and more than half reported improved disability.
Sweden
,
Stockholm
,
Uppsala
,
Uppsala-lan
,
Dalarna
,
Kopparberg
,
Swedish
,
Joachim-burman
,
Clinical-research-dalarna
,
Swedish-research-council
,
Marcus-wallenberg-foundation
,
Regional-research-council